文献速递焦虑、强迫与应激相关障碍

聚焦创伤的iCT-PTSD在英格兰的成本效果:基于STOP-PTSD试验的经济学评价

Cost-effectiveness of therapist-assisted internet-delivered psychological therapies for PTSD differing in trauma focus in England: an economic evaluation based on the STOP-PTSD trial.
PubMed 文献 · Lancet Psychiatry · 2024-03-27

基于STOP-PTSD单盲随机对照试验(n=217)的经济学评价,比较治疗师辅助的互联网认知疗法(iCT-PTSD)与压力管理项目(iStress-PTSD)。社会视角下iCT-PTSD节省成本。

要点

  • iCT-PTSD在39周时临床结局优于iStress-PTSD,NHS成本相近。
  • 社会视角下iCT-PTSD相比iStress-PTSD节省成本。

核心结论

  • iCT-PTSD相对于iStress-PTSD是具有成本效果的治疗师辅助互联网心理治疗,可考虑临床实施。

研究设计与样本

  • 基于STOP-PTSD单盲随机对照试验(n=217)的事先计划经济学评价,纳入符合DSM-5 PTSD诊断的≥18岁初级保健治疗服务使用者。
  • 干预为在线治疗师支持前12周及随后3个月三次电话通话,基线、13周、26周和39周完成问卷。
  • 采用意向性治疗完整病例分析,从英格兰NHS及个人社会服务视角评估每QALY成本。

主要发现

  • NHS成本在两组间相似,但iCT-PTSD临床结局优于iStress-PTSD。
  • NHS及个人社会服务视角的增量成本效果比为每QALY 1921英镑。
  • 社会视角下iCT-PTSD相比iStress-PTSD节省成本。

关键数值与推荐

  • 增量成本效果比:每QALY 1921英镑(NHS及个人社会服务视角,39周)。

临床怎么用

  • 对于PTSD患者,可优先考虑实施聚焦创伤的iCT-PTSD而非iStress-PTSD,因其临床结局更优且具成本效果。
  • 在NHS决策中,iCT-PTSD在常规阈值下极可能具有成本效果,支持其推广。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although there are effective psychological treatments for post-traumatic stress disorder (PTSD), they remain inaccessible for many people. Digitally enabled therapy is a way to overcome this problem; however, there is little evidence on which forms of these therapies are most cost effective in PTSD. We aimed to assess the cost-effectiveness of the STOP-PTSD trial, which evaluated two therapist-assisted, internet-delivered cognitive behavioural therapies: cognitive therapy for PTSD (iCT-PTSD) and a programme focusing on stress management (iStress-PTSD). METHODS: In this health economic evaluation, we used data from the STOP-PTSD trial (n=217), a single-blind, randomised controlled trial, to compare iCT-PTSD and iStress-PTSD in terms of resource use and health outcomes. In the trial, participants (aged ≥18 years) who met DSM-5 criteria for PTSD were recruited from primary care therapy services in South East England. The interventions were delivered online with therapist support for the first 12 weeks, and three telephone calls over the next 3 months. Participants completed questionnaires on symptoms, wellbeing, quality of life, and resource use at baseline, 13 weeks, 26 weeks, and 39 weeks after randomisation. We used a cost-effectiveness analysis to assess cost per quality-adjusted life year (QALY) at 39 weeks post-randomisation, from the perspective of the English National Health Service (NHS) and personal social services and on the basis of intention-to-treat for complete cases. Treatment modules and the platform design were developed with extensive input from service users: service users also advised on the trial protocol and methods, including the health economic measures. This is a pre-planned analysis of the STOP-PTSD trial; the trial was registered prospectively on the ISRCTN Registry (ISRCTN16806208). FINDINGS: NHS costs were similar across treatment groups, but clinical outcomes were superior for iCT-PTSD compared with iStress-PTSD. The incremental cost-effectiveness ratio for NHS costs and personal social services was estimated as £1921 per QALY. iCT-PTSD had an estimated 91·6% chance of being cost effective at the £20 000 per QALY threshold. From the societal perspective, iCT-PTSD was cost saving compared with iStress-PTSD. INTERPRETATION: iCT-PTSD is a cost-effective form of therapist-assisted, internet-delivered psychological therapy relative to iStress-PTSD, and it could be considered for clinical implementation. FUNDING: Wellcome Trust and National Institute of Health Research Oxford Health Biomedical Research Centre.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Penington E, Wild J, Warnock-Parkes E, et al. Cost-effectiveness of therapist-assisted internet-delivered psychological therapies for PTSD differing in trauma focus in England: an economic evaluation based on the STOP-PTSD trial. Lancet Psychiatry. 2024. PMID: 38554731. doi:10.1016/S2215-0366(24)00055-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。